HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ioanna Xagoraris Selected Research

SAM Domain and HD Domain-Containing Protein 1

1/2021Expression of the novel tumour suppressor sterile alpha motif and HD domain-containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma.
10/2018Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ioanna Xagoraris Research Topics

Disease

2Lymphoma (Lymphomas)
07/2023 - 02/2022
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
07/2023 - 01/2021
2Hodgkin Disease (Hodgkin's Disease)
11/2022 - 01/2021
2Neoplasms (Cancer)
11/2022 - 10/2018
1T-Cell Lymphoma (Lymphoma, T Cell)
07/2023
1Bites and Stings (Sting)
02/2022
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2020
1Histiocytic Sarcoma
03/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2018

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
11/2022 - 02/2022
2Proteins (Proteins, Gene)FDA Link
02/2022 - 01/2021
2SAM Domain and HD Domain-Containing Protein 1IBA
01/2021 - 10/2018
1InterferonsIBA
02/2022
1Messenger RNA (mRNA)IBA
02/2022
1Anaplastic Lymphoma KinaseIBA
01/2021
1trametinibIBA
03/2020
1dabrafenibIBA
03/2020
1Cytarabine (Cytosar-U)FDA LinkGeneric
10/2018

Therapy/Procedure

1Breast Implants (Breast Implant)
07/2023
1Therapeutics
10/2018
1Consolidation Chemotherapy
10/2018